id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
251,,,,,,,,,,,,,,,2024-06-10T13:38:30+06:00,BSH - H11903019646,B/Lateral,Letrozole,,,"2010 For Left Breast: Received 6 cycles of ADCT with Docetaxel + Doxorubicin from
24.11.2010 up to 10.03.2011 at Apollo. 2019 for Right Breast: Started Weekly Paclitaxel from 23.03.2019,
Week 12 till 10/06/19. Started Single Gemcitabine (D1 & D8) C1 from 01.07.2019. Cycle 6 Day 8 due on
06/11/19. Cycle 12 Inj. Zoledronic acid 23/02/20. On Tab Tamona.",2023-03-11,,2023-12-23,,2020-09-21,,2020-09-21,Breast,243,Upper middle class,BSBSC-240000243,SHAHEEN SULTANA,1733998884,1967-01-01,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Bilateral,,,Stable,Alive,CR,,,,,,,,,,,CR,,,,,,,,,,
